RB-001

N/A

Report date: 2025/07/08 16:57:11

Base Information

Drug NameRB-001
Drug Alias NameRB-001
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionSH3 and multiple ankyrin repeat domains protein 3 gene transference
TargetsSH3 and multiple ankyrin repeat domains protein 3
Therapy Area/IndicationsPhelan-McDermid syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShenzhen Reborngene Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Reborngene Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsPhelan-McDermid syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A